SMTL ID : 6yg9.1

CRYSTAL STRUCTURE OF HUMAN SERUM ALBUMIN (HSA) IN COMPLEX WITH GN-07.

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 1.89 Å

Oligo State

monomer

Ligands

6 x MYR: MYRISTIC ACID(Non-covalent)

MYR.1: 9 residues within 4Å: Chain A: R.117, M.123, Y.138, I.142, A.158, Y.161, F.165, L.182, R.186 13 PLIP interactions: 13 interactions with chain A Hydrophobic interactions: A:R.117, A:Y.138, A:Y.138, A:I.142, A:A.158, A:Y.161, A:Y.161, A:Y.161, A:Y.161, A:F.165, A:L.182 Salt bridges: A:R.117, A:R.186 MYR.2: 12 residues within 4Å: Chain A: Y.401, N.405, F.502, F.507, F.509, K.525, A.528, L.529, L.532, K.545, L.575, S.579 9 PLIP interactions: 9 interactions with chain A Hydrophobic interactions: A:F.502, A:F.509, A:F.509, A:K.525, A:A.528, A:L.529, A:L.532 Hydrogen bonds: A:N.405 Salt bridges: A:K.525 MYR.3: 7 residues within 4Å: Chain A: L.238, R.257, L.260, I.264, S.287, I.290, A.291 5 PLIP interactions: 5 interactions with chain A Hydrophobic interactions: A:L.238, A:L.260, A:I.264, A:I.290, A:A.291 MYR.4: 14 residues within 4Å: Chain A: S.342, V.344, L.345, R.348, P.384, L.387, I.388, N.391, L.430, M.446, A.449, L.453, R.485 Ligands: MYR.5 8 PLIP interactions: 8 interactions with chain A Hydrophobic interactions: A:V.344, A:P.384, A:L.387, A:N.391, A:A.449 Hydrogen bonds: A:S.342 Salt bridges: A:R.348, A:R.485 MYR.5: 13 residues within 4Å: Chain A: L.387, Y.411, V.415, V.418, L.423, V.426, L.453, L.457, L.460, V.473, F.488, S.489 Ligands: MYR.4 16 PLIP interactions: 16 interactions with chain A Hydrophobic interactions: A:Y.411, A:Y.411, A:Y.411, A:Y.411, A:V.418, A:L.423, A:V.426, A:L.453, A:L.457, A:V.473, A:F.488, A:F.488, A:F.488 Hydrogen bonds: A:Y.411, A:Y.411 Water bridges: A:N.391 MYR.6: 11 residues within 4Å: Chain A: R.209, A.210, A.213, V.216, D.324, L.327, G.328, L.347, A.350, K.351, E.354 9 PLIP interactions: 9 interactions with chain A Hydrophobic interactions: A:A.210, A:A.213, A:V.216, A:D.324, A:L.327, A:L.327, A:L.347, A:A.350 Water bridges: A:S.480

1 x OQ5: 20-[[(2~{S})-5-[2-[2-[2-[2-[2-[2-(diethylamino)-2-oxidanylidene-ethoxy]ethoxy]ethylamino]-2-oxidanylidene-ethoxy]ethoxy]ethylamino]-1-oxidanyl-1,5-bis(oxidanylidene)pentan-2-yl]amino]-20-oxidanylidene-icosanoic acid(Non-covalent)

OQ5.7: 19 residues within 4Å: Chain A: V.7, R.10, L.22, V.23, E.45, V.46, F.49, N.61, L.66, L.69, K.73, Y.150, P.152, A.254, R.257, A.258, L.283, L.284, S.287 20 PLIP interactions: 20 interactions with chain A Hydrophobic interactions: A:V.7, A:L.22, A:L.22, A:V.23, A:V.46, A:V.46, A:F.49, A:F.49, A:L.66, A:L.69, A:K.73, A:P.152, A:A.254, A:L.283 Hydrogen bonds: A:N.61, A:Y.150, A:S.287 Water bridges: A:S.287, A:S.287 Salt bridges: A:R.257

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Mishra, A. et al., Triantennary GalNAc Molecular Imaging Probes for Monitoring Hepatocyte Function in a Rat Model of Nonalcoholic Steatohepatitis. Adv Sci (2020)

Release Date

2021-01-13

Peptides

Serum albumin: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Serum albumin

Related Entries With Identical Sequence